Breast cancer: Further metabolic-endocrine risk markers?

British Journal of Cancer

Volumn 76, Issue 12, 1997, Pages 1652-1654

  Stoll, B A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer development; Growth hormone; Hyperinsulinaemia; Insulin resistance; Insulin like growth factor; Oestrogen receptor

Indexed keywords

ESTRADIOL; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

BIOAVAILABILITY; BREAST CANCER; CANCER RISK; ECTOPIC HORMONE PRODUCTION; HUMAN; INSULIN LIKE ACTIVITY; PRIORITY JOURNAL; SHORT SURVEY; XENOGRAFT;

EID: 0030726059     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.612     Document Type: Short Survey

References (44)

1. Berstein LM, Bobrov JF and Ostroumovq MN (1985) Relation of blood lipids and insulin to body fat content, body surface area and subcutaneous tissue in patients with breast and lung cancer. Vop Onkol 31: 44-51
2. Bruning BF, Bonfrer JMG, van Noord PAH, Hart AAM, de Jong Bakker M and Nooijen WY (1992) Insulin resistance and breast cancer risk. Int J Cancer 52: 511-516
3. Bruning PF, van Doorn J, Bonfrer JMG, van Noord PAH, Korse CM, Linders TC and Hart AAM (1995) 1GFBP3 is decreased in early stage operable premenopausal breast cancer. Int J Cancer 62: 266-270
4. Chaudhari B, Crist KA, Mucci S, Malafa M and Chaudhuri PK (1993) Distribution of estrogen receptor in ductal carcinoma in situ of the breast. Surgery 113. 134-137
5. Clarke RB, Howell A and Anderson E (1997) Type 1 IGF receptor gene expression in normal breast tissue treated with oestrogen and progesterone. Br J Cancer 75: 251-257
6. Copeland GR, Leinster SJ, Davis JC and Hipkin LJ (1987) Insulin resistance in patients with colorectal cancer. Br J Surg 74: 1031-1035
7. Daniell HW (1988) The influence of obesity and age at diagnosis on the estrogen receptor status of breast cancers. Perimenopausal predominance of estrogen receptor negative tumors. Cancer 61: 1237-1240
8. Darendeliler F, Hindmarsh PC and Preece MA (1990) Growth hormone increases rate of pubertal maturation. Acta Endocrinol 122: 414-416
9. Drafta D, Priscu A, Neacsu E, Gangura M, Schindler AE and Stroe E (1983) Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level. J Steroid Biochem 18: 459-463
10. Ellis MJC, Singer C, Hornby A, Rasmussen A and Cullen KJ (1994) Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 31: 249-261
11. Favoni RE, de Cupis A, Perrotta A, Sforzini S, Amoroso D, Pensa F and Miglietta L (1995) IGF1 and IGFBP blood serum levels in women with early and late stage breast cancer. J Cancer Res Clin Oncol 121: 674-682
12. Feldman M, Ruan W, Cunningham BC, Wells JA and Kleinberg DL (1993) Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland. Endocrinology 133: 1602-1608
13. Foekens JA, Portengen H, Janssen M and Klijn JG (1989) IGF1 receptors and IGF1-like activity in human primary breast cancer. Cancer 63: 2139-2147
14. Frost VJ, Helle SJ, Lonning PE, van der Stappen JWJ and Holly JMP (1996) Effect of treatment on IGF, IGFBPs and IGFBP3 protease status in patients with advanced breast cancer. J Clin Endocrinol Metab 81: 2216-2221
15. Giovanucci E (1995) Insulin and colon cancer. Cancer Causes Control 6: 164-179
16. Giudice LC (1995) Editorial; IGFBP3 protease regulation: How sweet it is. J Clin Endocrinol Metab 80: 2279-2281
17. Heslin MJ, Newman E, Wolf RF, Pisters PWT and Brennan MF (1992) Effect of systemic hyperinsulinemia in cancer patients. Cancer Res 52: 3845-3850
18. Holly JMP (1991) The physiological role of IGFBP1. Acta Endocrinol 124 (suppl. 2): 55-62
19. Jacquemier JD, Hassoun J, Torrente M and Martin PM (1990) Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages; immunohistochemical study of 107 cases. Breast Cancer Res Treat 15: 109-117
20. Juul A, Main K and Blum WF (1994) The ratio between serum levels of IGF1 and IGFBP 1, 2, 3 decreases with age in healthy adults and is increased in acromegalic patients. J Clin Endocrinol Metab 41: 85-93
21. Khan SA, Rogers MAM, Obando JA and Tamsen A (1994) Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54: 993-997
22. Kleinberg DL, Ruan W, Catanese V, Newman CB and Feldman M (1990) Non-lactogenic effects of growth hormone on growth and IGF1 mRNA of rat mammary gland. Endocrinology 126: 3274-3276
23. McGuire SE, Hilsenbeck SG, Figueroa JA, Jackson JG and Yee D (1994) Detection of IGFBPs by ligand blotting in breast cancer tissues. Cancer letters 77: 25-32
24. Markopoulos C, Berger U, Wilson P, Gavel JC and Coombes PC (1988) Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J 296: 1349-1351
25. Matsumoto, K, Sakamoto G and Nomura Y (1986) International comparisons concerning breast cancer and steroid receptors. Anticancer Res 6: 621-624
26. Mehta RR, Hart G and Das Gupta TK (1992) Steroid receptors in breast cancer patients; influence of obesity and age at diagnosis. Anticancer Res 12: 1311-1314
27. Mol JA, Henzen Longmans SC, Hageman P, Misdorp W, Blankenstein MA and Rijnberk A (1945) Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocrinol Metab 80: 3094-3096
28. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Yamaguchi FY, Vigneri R, Goldfine JD and Pezzino V (1993) IGF1 receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53: 3736-3740
29. Pekonen F, Partanen S, Makinen T and Rutanen EM (1988) Receptors for EGF and IGF1 and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343-1347
30. Peyrat JP, Bonneterre J, Beuscart R, Djiane J and Demaille A (1988) IGF1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 48: 6429-6433
31. Peyral JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C and Demaille A (1993) Plasma IGF1 concentration in human breast cancer, Eur J Cancer 29A: 492-497
32. Railo MJ, von Smitten K and Pekonen F (1994) The prognostic value of IGF1 in breast cancer patients. Results of a follow-up study in 126 patients. Eur J Cancer 30A: 307-311
33. Reaven GM (1988) Role of insulin resistance in human disease. Banting Lecture 1988. Diabetes 37: 1595-1607
34. Ricketts D, Turnbull L, Ryall G, Bakshi R, Rawson NSB, Gazet JC, Nolan C and Coombes RC (1991) Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817-1822
35. Rutanen EM, Stenman S, Blum W, Karkkainen T, Lehtovirta P and Stenman WH (1993) Relationship between carbohydrate metabolism and serum IGF system in postmenopausal women; comparison of endometrial cancer patients with healthy controls, J Clin Endocrinol Metab 77: 199-204
36. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT and Cullen KJ (1995) Malignant breast epithelium selects for IGF 11 expression in breast stroma; evidence for paracrine function. Cancer Res 55: 2448-2254
37. Tekden M, Kahraman H, Yucel J, Adam B, Yildiz C and Tanyeri F (1996) Insulin and C-peptide response to oral glucose in patients with breast cancer. Ann Oncol 7 (suppl. 5): 24
38. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS and Plymate SR (1996) IGFBP2 and IGFBP3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia and adenocarcinoma of the prostate. J Clin Endocrin Metab 81: 411-420
39. Vishnevsky AS, Bobrov JF, Tsyrlina EV and Dilman VM (1993) Hyperinsulinemia as a factor modifying sensitivity of endometrial cancer to hormonal influences. Eur J Gyn Oncol 14: 127-130
40. Westley BR and May FE (1994) Role of IGF in steroid-modulated proliferation. J Ster Biochem Mol Biol 51: 1-9
41. Yam D, Ben-Hur H, Fink A, Dgani R, Shani A, Eliraz A, Insler V and Berry EM (1994) Insulin and glucose status, tissue and plasma lipids in patients with tumours of the ovary or endometrium: possible dietary implications. Br J Cancer 70: 1186-1187
42. Yee D (1994) The IGF system as a target in breast cancer. Breast Cancer Res Treat 32: 85-95
43. Yoshikawa T, Noguchi Y and Matsumoto A (1994) Effects of tumour removal and body weight loss on insulin resistance in patients with cancer. Surgery 116: 62-66
44. Yu H, Levesque MA, Khosravi MJ, Diamandi AP, Clark CM and Diamandis EP (1996) Association between IGFs and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 74: 1242-1247